

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.19282294 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 7.19282294 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 7.19282294 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 7.19282294 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.19282294 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.19282294 |
| 7 | response to peptidoglycan (GO:0032494) | 5.48056233 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.32367787 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.18580471 |
| 10 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.80621228 |
| 11 | response to host immune response (GO:0052572) | 4.80621228 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.79785931 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.70711181 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.64015917 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 4.50533010 |
| 16 | respiratory burst (GO:0045730) | 4.48162791 |
| 17 | microglial cell activation (GO:0001774) | 4.47321629 |
| 18 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.47263091 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.42322699 |
| 20 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.36361007 |
| 21 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.29561636 |
| 22 | response to host (GO:0075136) | 4.29561636 |
| 23 | response to host defenses (GO:0052200) | 4.29561636 |
| 24 | positive regulation of heat generation (GO:0031652) | 4.21959946 |
| 25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.17205146 |
| 26 | response to muramyl dipeptide (GO:0032495) | 4.08619422 |
| 27 | granulocyte activation (GO:0036230) | 4.03554520 |
| 28 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.02524712 |
| 29 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.99886574 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.99476251 |
| 31 | glycosphingolipid catabolic process (GO:0046479) | 3.93641100 |
| 32 | regulation of fever generation (GO:0031620) | 3.87093151 |
| 33 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.86311611 |
| 34 | detection of other organism (GO:0098543) | 3.84884366 |
| 35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.80880417 |
| 36 | neutrophil activation (GO:0042119) | 3.79594620 |
| 37 | amino sugar catabolic process (GO:0046348) | 3.72796554 |
| 38 | macrophage activation (GO:0042116) | 3.72363873 |
| 39 | oligosaccharide catabolic process (GO:0009313) | 3.70420110 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.68378104 |
| 41 | superoxide anion generation (GO:0042554) | 3.65019689 |
| 42 | natural killer cell mediated immunity (GO:0002228) | 3.62485886 |
| 43 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.62485886 |
| 44 | detection of bacterium (GO:0016045) | 3.58590411 |
| 45 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.56676779 |
| 46 | positive regulation of mast cell degranulation (GO:0043306) | 3.55979515 |
| 47 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.55979515 |
| 48 | regulation of mononuclear cell migration (GO:0071675) | 3.55734842 |
| 49 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.55376713 |
| 50 | regulation of chemokine biosynthetic process (GO:0045073) | 3.53722644 |
| 51 | glycolipid catabolic process (GO:0019377) | 3.52388944 |
| 52 | detection of external biotic stimulus (GO:0098581) | 3.50992543 |
| 53 | reactive oxygen species biosynthetic process (GO:1903409) | 3.49062438 |
| 54 | cellular response to type I interferon (GO:0071357) | 3.45770051 |
| 55 | type I interferon signaling pathway (GO:0060337) | 3.45770051 |
| 56 | negative regulation of interleukin-12 production (GO:0032695) | 3.43995632 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.43937739 |
| 58 | response to type I interferon (GO:0034340) | 3.42829323 |
| 59 | positive regulation of interferon-beta production (GO:0032728) | 3.41721584 |
| 60 | positive regulation of mast cell activation (GO:0033005) | 3.41236515 |
| 61 | regulation of antigen processing and presentation (GO:0002577) | 3.38467334 |
| 62 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.29310479 |
| 63 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.28790131 |
| 64 | B cell mediated immunity (GO:0019724) | 3.26352733 |
| 65 | detection of molecule of bacterial origin (GO:0032490) | 3.23984614 |
| 66 | myeloid dendritic cell activation (GO:0001773) | 3.23892513 |
| 67 | negative regulation of interleukin-17 production (GO:0032700) | 3.22337102 |
| 68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22031953 |
| 69 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.21801437 |
| 70 | T-helper 1 type immune response (GO:0042088) | 3.21528853 |
| 71 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.20981953 |
| 72 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.20965941 |
| 73 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.20768256 |
| 74 | defense response to protozoan (GO:0042832) | 3.19827892 |
| 75 | cellular extravasation (GO:0045123) | 3.19203257 |
| 76 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.18934358 |
| 77 | I-kappaB phosphorylation (GO:0007252) | 3.17477864 |
| 78 | leukocyte aggregation (GO:0070486) | 3.17247814 |
| 79 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.16942450 |
| 80 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16388850 |
| 81 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.15349263 |
| 82 | regulation of heat generation (GO:0031650) | 3.14270418 |
| 83 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.13940238 |
| 84 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.12368054 |
| 85 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.12368054 |
| 86 | neutrophil mediated immunity (GO:0002446) | 3.12199518 |
| 87 | detection of biotic stimulus (GO:0009595) | 3.11908462 |
| 88 | positive regulation of interleukin-12 production (GO:0032735) | 3.10066179 |
| 89 | ceramide catabolic process (GO:0046514) | 3.09931181 |
| 90 | low-density lipoprotein particle clearance (GO:0034383) | 3.09857789 |
| 91 | regulation of leukocyte degranulation (GO:0043300) | 3.09536279 |
| 92 | response to protozoan (GO:0001562) | 3.08893915 |
| 93 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.08527559 |
| 94 | leukocyte mediated cytotoxicity (GO:0001909) | 3.07803513 |
| 95 | monocyte chemotaxis (GO:0002548) | 3.07372346 |
| 96 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.07008889 |
| 97 | regulation of mast cell activation (GO:0033003) | 3.00961664 |
| 98 | positive regulation of chemokine production (GO:0032722) | 3.00455295 |
| 99 | regulation of cholesterol storage (GO:0010885) | 3.00354562 |
| 100 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99924112 |
| 101 | NIK/NF-kappaB signaling (GO:0038061) | 2.99916840 |
| 102 | eosinophil chemotaxis (GO:0048245) | 2.99704000 |
| 103 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.99235944 |
| 104 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.99043285 |
| 105 | negative regulation of cell killing (GO:0031342) | 2.98709231 |
| 106 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.98709231 |
| 107 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.98239905 |
| 108 | myeloid dendritic cell differentiation (GO:0043011) | 2.95992615 |
| 109 | N-acetylneuraminate metabolic process (GO:0006054) | 2.95955640 |
| 110 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.95165392 |
| 111 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.94952648 |
| 112 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.93589490 |
| 113 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.91704098 |
| 114 | cytokine secretion (GO:0050663) | 2.91125910 |
| 115 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91092227 |
| 116 | germinal center formation (GO:0002467) | 2.90759404 |
| 117 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.89676570 |
| 118 | positive regulation of leukocyte degranulation (GO:0043302) | 2.89406049 |
| 119 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.89278117 |
| 120 | regulation of interleukin-17 production (GO:0032660) | 2.89011412 |
| 121 | regulation of T cell tolerance induction (GO:0002664) | 2.88215516 |
| 122 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.88212809 |
| 123 | negative regulation of viral genome replication (GO:0045071) | 2.88100652 |
| 124 | regulation of podosome assembly (GO:0071801) | 2.87555746 |
| 125 | positive regulation of type 2 immune response (GO:0002830) | 2.86096730 |
| 126 | regulation of interleukin-12 production (GO:0032655) | 2.84892403 |
| 127 | dendritic cell differentiation (GO:0097028) | 2.84582378 |
| 128 | cellular response to interferon-gamma (GO:0071346) | 2.83706431 |
| 129 | regulation of macrophage chemotaxis (GO:0010758) | 2.79328438 |
| 130 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.77624617 |
| 131 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.76149735 |
| 132 | response to thyroid hormone (GO:0097066) | 2.72771195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.22346267 |
| 2 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.65706921 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.55571522 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.81960447 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.57002035 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.12601395 |
| 7 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.10050360 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.97709307 |
| 9 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.91966394 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.22324593 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21042305 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.13295456 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.01342904 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.97479683 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92493379 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.77037430 |
| 17 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53838947 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.53124236 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42122107 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32055044 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18104648 |
| 22 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.07133538 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.04923501 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96042171 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.85325343 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84786071 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84627879 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82913378 |
| 29 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.80041358 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78927415 |
| 31 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.76274671 |
| 32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75460824 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74364970 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65648013 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.64890831 |
| 36 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64764781 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64697697 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59133573 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58251301 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52140635 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.49984214 |
| 42 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.49935552 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.47975880 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.42929705 |
| 45 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40917876 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38817318 |
| 47 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38693627 |
| 48 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37022362 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36874545 |
| 50 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31705917 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29601500 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25527110 |
| 53 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22963374 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21718169 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.21138708 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21087964 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19803874 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19760501 |
| 59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19288238 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18501675 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17028285 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14756158 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13976700 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08806667 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07688853 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07304486 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07004274 |
| 68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02666023 |
| 69 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01747807 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00616794 |
| 71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00148283 |
| 72 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00008589 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98780900 |
| 74 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97074989 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94620999 |
| 76 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94498137 |
| 77 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94429132 |
| 78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93821166 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93209972 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93197060 |
| 81 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.92156888 |
| 82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92033138 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90408515 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89029034 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88734227 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88734227 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87730652 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87542373 |
| 89 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86251681 |
| 90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86149556 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86072052 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85714024 |
| 93 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.85671021 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85038767 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84407950 |
| 96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83136868 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82945042 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82497742 |
| 99 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80555841 |
| 100 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77524459 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76907058 |
| 102 | * MAF_26560356_Chip-Seq_TH2_Human | 0.74376071 |
| 103 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71566032 |
| 104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70512479 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70330268 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70238692 |
| 107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70073748 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68687870 |
| 109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67974558 |
| 110 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.66591462 |
| 111 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.66367858 |
| 112 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.65524363 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.63831109 |
| 114 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.63685511 |
| 115 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.62812323 |
| 116 | CJUN_26792858_Chip-Seq_BT549_Human | 0.62558223 |
| 117 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.61085449 |
| 118 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.61085449 |
| 119 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.60818393 |
| 120 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.60148890 |
| 121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.59916894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.51517850 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.13603405 |
| 3 | MP0003436_decreased_susceptibility_to | 3.86677321 |
| 4 | MP0009785_altered_susceptibility_to | 3.71234465 |
| 5 | MP0006082_CNS_inflammation | 3.37266415 |
| 6 | MP0004510_myositis | 3.34490126 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.28856858 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.28451282 |
| 9 | MP0002419_abnormal_innate_immunity | 3.27976721 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.15297370 |
| 11 | MP0001790_abnormal_immune_system | 2.91437251 |
| 12 | MP0005387_immune_system_phenotype | 2.91437251 |
| 13 | MP0005025_abnormal_response_to | 2.90375553 |
| 14 | MP0003724_increased_susceptibility_to | 2.87163993 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.63784871 |
| 16 | MP0000685_abnormal_immune_system | 2.48889270 |
| 17 | MP0001800_abnormal_humoral_immune | 2.45975424 |
| 18 | MP0002723_abnormal_immune_serum | 2.45866304 |
| 19 | MP0005671_abnormal_response_to | 2.40069033 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.38436383 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.18385817 |
| 22 | MP0001819_abnormal_immune_cell | 2.14435206 |
| 23 | MP0004947_skin_inflammation | 2.14149199 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.10977703 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.07970933 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 2.00118913 |
| 27 | MP0009278_abnormal_bone_marrow | 1.99844203 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.99232255 |
| 29 | MP0003448_altered_tumor_morphology | 1.96426993 |
| 30 | MP0002405_respiratory_system_inflammati | 1.88961572 |
| 31 | MP0009764_decreased_sensitivity_to | 1.88921032 |
| 32 | MP0009840_abnormal_foam_cell | 1.88739817 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.85981159 |
| 34 | MP0005451_abnormal_body_composition | 1.83477384 |
| 35 | MP0003075_altered_response_to | 1.81908622 |
| 36 | MP0000343_altered_response_to | 1.75431927 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.74582619 |
| 38 | MP0008469_abnormal_protein_level | 1.72452619 |
| 39 | MP0001853_heart_inflammation | 1.72268616 |
| 40 | MP0000604_amyloidosis | 1.71554633 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.61953389 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.60556348 |
| 43 | MP0005310_abnormal_salivary_gland | 1.48761067 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.48264141 |
| 45 | MP0000716_abnormal_immune_system | 1.45790189 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.44806102 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.44716472 |
| 48 | MP0004858_abnormal_nervous_system | 1.40772882 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.36100015 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.34120599 |
| 51 | MP0002398_abnormal_bone_marrow | 1.31664365 |
| 52 | MP0002254_reproductive_system_inflammat | 1.31066467 |
| 53 | MP0005166_decreased_susceptibility_to | 1.30150312 |
| 54 | MP0000858_altered_metastatic_potential | 1.28754018 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.28682260 |
| 56 | MP0008004_abnormal_stomach_pH | 1.28153100 |
| 57 | MP0003690_abnormal_glial_cell | 1.28112922 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.25812502 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.25097516 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.25097516 |
| 61 | MP0002006_tumorigenesis | 1.23216432 |
| 62 | MP0003329_amyloid_beta_deposits | 1.18242000 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.17395533 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.17056624 |
| 65 | MP0008260_abnormal_autophagy | 1.15103206 |
| 66 | MP0002429_abnormal_blood_cell | 1.13263785 |
| 67 | MP0001851_eye_inflammation | 1.12264186 |
| 68 | MP0005164_abnormal_response_to | 1.11504240 |
| 69 | MP0010307_abnormal_tumor_latency | 1.07657321 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.07537705 |
| 71 | MP0005390_skeleton_phenotype | 1.02607002 |
| 72 | MP0002722_abnormal_immune_system | 1.01579134 |
| 73 | MP0002933_joint_inflammation | 0.99807985 |
| 74 | MP0006054_spinal_hemorrhage | 0.99469296 |
| 75 | MP0003828_pulmonary_edema | 0.97717663 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.96020212 |
| 77 | MP0009763_increased_sensitivity_to | 0.95639580 |
| 78 | MP0003195_calcinosis | 0.92939429 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 0.92357732 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 0.85591083 |
| 81 | MP0005083_abnormal_biliary_tract | 0.84285316 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.83690038 |
| 83 | MP0003763_abnormal_thymus_physiology | 0.79588337 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.78860247 |
| 85 | MP0003091_abnormal_cell_migration | 0.78843189 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.78696414 |
| 87 | MP0000371_diluted_coat_color | 0.76944767 |
| 88 | MP0003186_abnormal_redox_activity | 0.76340899 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.76267086 |
| 90 | MP0000249_abnormal_blood_vessel | 0.74541850 |
| 91 | MP0002166_altered_tumor_susceptibility | 0.72385935 |
| 92 | MP0005365_abnormal_bile_salt | 0.72138943 |
| 93 | MP0005165_increased_susceptibility_to | 0.71882964 |
| 94 | MP0008874_decreased_physiological_sensi | 0.71570682 |
| 95 | MP0001542_abnormal_bone_strength | 0.70833848 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.70668254 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.68150419 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.67909870 |
| 99 | MP0003795_abnormal_bone_structure | 0.67353605 |
| 100 | MP0003279_aneurysm | 0.63014910 |
| 101 | MP0002877_abnormal_melanocyte_morpholog | 0.61455439 |
| 102 | MP0005647_abnormal_sex_gland | 0.61425815 |
| 103 | MP0001873_stomach_inflammation | 0.60167846 |
| 104 | MP0001663_abnormal_digestive_system | 0.59328812 |
| 105 | MP0002090_abnormal_vision | 0.58154640 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.57473320 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.57060853 |
| 108 | MP0005197_abnormal_uvea_morphology | 0.54980887 |
| 109 | MP0000767_abnormal_smooth_muscle | 0.54976954 |
| 110 | MP0003866_abnormal_defecation | 0.54840249 |
| 111 | MP0000920_abnormal_myelination | 0.54663585 |
| 112 | MP0001958_emphysema | 0.54150277 |
| 113 | MP0000490_abnormal_crypts_of | 0.54062373 |
| 114 | MP0001849_ear_inflammation | 0.53754918 |
| 115 | MP0000609_abnormal_liver_physiology | 0.53484765 |
| 116 | MP0003045_fibrosis | 0.53461833 |
| 117 | MP0003634_abnormal_glial_cell | 0.53114350 |
| 118 | MP0003646_muscle_fatigue | 0.52346348 |
| 119 | MP0005023_abnormal_wound_healing | 0.51712112 |
| 120 | MP0004883_abnormal_blood_vessel | 0.51636862 |
| 121 | MP0010352_gastrointestinal_tract_polyps | 0.51622196 |
| 122 | MP0010386_abnormal_urinary_bladder | 0.51239796 |
| 123 | MP0004808_abnormal_hematopoietic_stem | 0.50205575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.33676438 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.98930733 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.59813576 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.22977468 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.57388532 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.24380367 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 5.00413360 |
| 8 | Stomatitis (HP:0010280) | 4.95802148 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.59190257 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.42115185 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 4.41467895 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.39373295 |
| 13 | Orchitis (HP:0100796) | 4.30660192 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 4.25230807 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 4.19467149 |
| 16 | Optic neuritis (HP:0100653) | 4.19467149 |
| 17 | Gingivitis (HP:0000230) | 4.14795606 |
| 18 | Myositis (HP:0100614) | 4.13999782 |
| 19 | Recurrent skin infections (HP:0001581) | 4.04671094 |
| 20 | Obstructive lung disease (HP:0006536) | 4.01917225 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 4.01917225 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.70548205 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.70548205 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 3.70548205 |
| 25 | Axonal loss (HP:0003447) | 3.68431748 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.66838618 |
| 27 | Vasculitis (HP:0002633) | 3.54482723 |
| 28 | Mutism (HP:0002300) | 3.45799892 |
| 29 | Disinhibition (HP:0000734) | 3.29462003 |
| 30 | Dysostosis multiplex (HP:0000943) | 3.27183907 |
| 31 | Glomerulonephritis (HP:0000099) | 3.16416089 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.11760485 |
| 33 | Urticaria (HP:0001025) | 3.05914509 |
| 34 | Basal ganglia calcification (HP:0002135) | 3.05259519 |
| 35 | Tetraparesis (HP:0002273) | 3.04168374 |
| 36 | Neurofibrillary tangles (HP:0002185) | 3.03388095 |
| 37 | Thick nail (HP:0001805) | 3.00698108 |
| 38 | Increased IgM level (HP:0003496) | 2.99694136 |
| 39 | Interstitial pulmonary disease (HP:0006530) | 2.97242821 |
| 40 | Cellulitis (HP:0100658) | 2.95309674 |
| 41 | Prostate neoplasm (HP:0100787) | 2.94491798 |
| 42 | Recurrent viral infections (HP:0004429) | 2.93399401 |
| 43 | Myocardial infarction (HP:0001658) | 2.91881404 |
| 44 | Purpura (HP:0000979) | 2.88081797 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.80752579 |
| 46 | Periodontitis (HP:0000704) | 2.76011707 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.71289611 |
| 48 | Recurrent cutaneous fungal infections (HP:0011370) | 2.71289611 |
| 49 | Chronic otitis media (HP:0000389) | 2.71120811 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.68340923 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.68340923 |
| 52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.67225209 |
| 53 | Osteomyelitis (HP:0002754) | 2.64737918 |
| 54 | Leukocytosis (HP:0001974) | 2.61443181 |
| 55 | Increased serum ferritin (HP:0003281) | 2.61143122 |
| 56 | Pustule (HP:0200039) | 2.60058980 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.59642129 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.59100711 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.59100711 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.59100711 |
| 61 | Meningitis (HP:0001287) | 2.58713880 |
| 62 | Nuclear cataract (HP:0100018) | 2.58652866 |
| 63 | Loss of speech (HP:0002371) | 2.55984566 |
| 64 | Recurrent pneumonia (HP:0006532) | 2.53964951 |
| 65 | Apathy (HP:0000741) | 2.53557785 |
| 66 | Diminished motivation (HP:0000745) | 2.52016274 |
| 67 | Neuronal loss in central nervous system (HP:0002529) | 2.51344934 |
| 68 | Agnosia (HP:0010524) | 2.48547746 |
| 69 | Arterial thrombosis (HP:0004420) | 2.46010302 |
| 70 | Hematochezia (HP:0002573) | 2.40312006 |
| 71 | Amyloidosis (HP:0011034) | 2.39777359 |
| 72 | Bone pain (HP:0002653) | 2.36364594 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.36215000 |
| 74 | Progressive neurologic deterioration (HP:0002344) | 2.32956292 |
| 75 | Inappropriate behavior (HP:0000719) | 2.30026645 |
| 76 | Premature loss of primary teeth (HP:0006323) | 2.28096735 |
| 77 | Hemoptysis (HP:0002105) | 2.26532619 |
| 78 | Gastrointestinal infarctions (HP:0005244) | 2.26224571 |
| 79 | Hypergammaglobulinemia (HP:0010702) | 2.22341758 |
| 80 | Nephritis (HP:0000123) | 2.22333158 |
| 81 | Complement deficiency (HP:0004431) | 2.21236472 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.18171134 |
| 83 | Encephalitis (HP:0002383) | 2.18010461 |
| 84 | Cerebral inclusion bodies (HP:0100314) | 2.17016173 |
| 85 | Vertebral compression fractures (HP:0002953) | 2.16350738 |
| 86 | Gingival bleeding (HP:0000225) | 2.15065784 |
| 87 | Recurrent lower respiratory tract infections (HP:0002783) | 2.15063770 |
| 88 | Restrictive lung disease (HP:0002091) | 2.13868495 |
| 89 | Pathologic fracture (HP:0002756) | 2.10131848 |
| 90 | Malnutrition (HP:0004395) | 2.09611072 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.09350290 |
| 92 | T lymphocytopenia (HP:0005403) | 2.09267093 |
| 93 | Increased IgE level (HP:0003212) | 2.09114158 |
| 94 | Personality changes (HP:0000751) | 2.08582077 |
| 95 | Polyneuropathy (HP:0001271) | 2.06677296 |
| 96 | Metaphyseal irregularity (HP:0003025) | 2.03674594 |
| 97 | Joint hemorrhage (HP:0005261) | 2.03574103 |
| 98 | Asymmetric septal hypertrophy (HP:0001670) | 2.02567106 |
| 99 | Anorexia (HP:0002039) | 1.98634222 |
| 100 | Abnormality of complement system (HP:0005339) | 1.97150359 |
| 101 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96961835 |
| 102 | Osteolytic defects of the hand bones (HP:0009699) | 1.96961835 |
| 103 | Dementia (HP:0000726) | 1.96876547 |
| 104 | J-shaped sella turcica (HP:0002680) | 1.94874849 |
| 105 | Nasal polyposis (HP:0100582) | 1.93992874 |
| 106 | Eosinophilia (HP:0001880) | 1.93561245 |
| 107 | Arthralgia (HP:0002829) | 1.92552370 |
| 108 | Colitis (HP:0002583) | 1.91983417 |
| 109 | Progressive visual loss (HP:0000529) | 1.91845557 |
| 110 | Porencephaly (HP:0002132) | 1.91437837 |
| 111 | Abnormality of T cell number (HP:0011839) | 1.90079686 |
| 112 | Pulmonary embolism (HP:0002204) | 1.90066564 |
| 113 | Peripheral demyelination (HP:0011096) | 1.89908084 |
| 114 | Gangrene (HP:0100758) | 1.89476741 |
| 115 | Poor head control (HP:0002421) | 1.88027576 |
| 116 | Upper motor neuron abnormality (HP:0002127) | 1.87598490 |
| 117 | Spontaneous hematomas (HP:0007420) | 1.86105630 |
| 118 | Albinism (HP:0001022) | 1.85979424 |
| 119 | Memory impairment (HP:0002354) | 1.84752256 |
| 120 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.84229773 |
| 121 | Prolonged neonatal jaundice (HP:0006579) | 1.83516989 |
| 122 | Petechiae (HP:0000967) | 1.83193545 |
| 123 | Inflammation of the large intestine (HP:0002037) | 1.82833674 |
| 124 | Abnormality of the pericardium (HP:0001697) | 1.81250915 |
| 125 | Esophageal neoplasm (HP:0100751) | 1.80825337 |
| 126 | Neoplasm of head and neck (HP:0012288) | 1.80825337 |
| 127 | Nausea (HP:0002018) | 1.79892000 |
| 128 | Sepsis (HP:0100806) | 1.78775956 |
| 129 | Abnormality of the nasal mucosa (HP:0000433) | 1.78661553 |
| 130 | Gastrointestinal stroma tumor (HP:0100723) | 1.78529299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.49784910 |
| 2 | MAP3K14 | 4.43514735 |
| 3 | TBK1 | 3.92542053 |
| 4 | IRAK3 | 3.84198012 |
| 5 | BLK | 3.57273937 |
| 6 | PBK | 3.41323514 |
| 7 | TYK2 | 3.15850292 |
| 8 | IRAK4 | 3.11084565 |
| 9 | MAP4K1 | 2.87828177 |
| 10 | IKBKE | 2.70388078 |
| 11 | IKBKB | 2.55676519 |
| 12 | PRPF4B | 2.34752341 |
| 13 | KIT | 2.23324511 |
| 14 | JAK3 | 2.12834899 |
| 15 | ERN1 | 2.04360622 |
| 16 | FGR | 2.00607804 |
| 17 | TAOK1 | 1.93181542 |
| 18 | JAK1 | 1.91698205 |
| 19 | MAP3K13 | 1.90913215 |
| 20 | TXK | 1.89014367 |
| 21 | DDR2 | 1.83854798 |
| 22 | CSK | 1.71182284 |
| 23 | PIM2 | 1.65398449 |
| 24 | CHUK | 1.57034503 |
| 25 | FES | 1.49087926 |
| 26 | CDC42BPA | 1.48234737 |
| 27 | CSF1R | 1.43208134 |
| 28 | SYK | 1.40678913 |
| 29 | EPHB1 | 1.40052597 |
| 30 | HCK | 1.39650069 |
| 31 | TGFBR2 | 1.33009570 |
| 32 | TAOK3 | 1.28506820 |
| 33 | ZAP70 | 1.24848873 |
| 34 | ABL2 | 1.22682524 |
| 35 | LYN | 1.18486430 |
| 36 | ACVR1B | 1.16046564 |
| 37 | JAK2 | 1.14582896 |
| 38 | MATK | 1.12494966 |
| 39 | RPS6KA4 | 1.10526358 |
| 40 | TNK2 | 1.08889544 |
| 41 | LCK | 1.07947721 |
| 42 | MARK3 | 1.06909536 |
| 43 | NEK9 | 1.06379628 |
| 44 | SIK2 | 1.03798809 |
| 45 | BMX | 1.01025600 |
| 46 | TESK2 | 0.94490742 |
| 47 | NME2 | 0.93610345 |
| 48 | BMPR2 | 0.90944073 |
| 49 | CAMKK2 | 0.90544378 |
| 50 | MAP3K10 | 0.89717751 |
| 51 | ARAF | 0.89335906 |
| 52 | PIM1 | 0.86623862 |
| 53 | BTK | 0.86552476 |
| 54 | SIK3 | 0.81559737 |
| 55 | GRK7 | 0.78352078 |
| 56 | EGFR | 0.77047641 |
| 57 | STK10 | 0.76933489 |
| 58 | IRAK1 | 0.74659038 |
| 59 | MAP3K11 | 0.72736211 |
| 60 | MAP3K5 | 0.71653706 |
| 61 | YES1 | 0.71438622 |
| 62 | ADRBK2 | 0.70471572 |
| 63 | ABL1 | 0.70035549 |
| 64 | EPHA3 | 0.66755652 |
| 65 | CLK1 | 0.66698858 |
| 66 | EIF2AK2 | 0.65645534 |
| 67 | PTK6 | 0.64875799 |
| 68 | STK4 | 0.64838645 |
| 69 | PRKCD | 0.64310726 |
| 70 | RPS6KL1 | 0.59357836 |
| 71 | RPS6KC1 | 0.59357836 |
| 72 | MAPK7 | 0.59036483 |
| 73 | KSR2 | 0.57408383 |
| 74 | MOS | 0.57262663 |
| 75 | IRAK2 | 0.56951913 |
| 76 | MARK2 | 0.56749641 |
| 77 | MAP3K1 | 0.55114721 |
| 78 | MST4 | 0.54915717 |
| 79 | FGFR4 | 0.54292382 |
| 80 | GRK6 | 0.54018544 |
| 81 | TRIB3 | 0.52426384 |
| 82 | MAPK12 | 0.51728308 |
| 83 | TEC | 0.50347890 |
| 84 | FGFR3 | 0.49861098 |
| 85 | MAP2K3 | 0.49470405 |
| 86 | DAPK3 | 0.49313350 |
| 87 | SIK1 | 0.48553872 |
| 88 | RPS6KA2 | 0.48420906 |
| 89 | MST1R | 0.48062332 |
| 90 | CAMK1D | 0.47726155 |
| 91 | TTN | 0.47637430 |
| 92 | PRKD2 | 0.46856367 |
| 93 | MAP2K6 | 0.46789048 |
| 94 | FYN | 0.46381291 |
| 95 | DAPK2 | 0.43457257 |
| 96 | TESK1 | 0.43445916 |
| 97 | TYRO3 | 0.41102721 |
| 98 | PRKCQ | 0.41043321 |
| 99 | LRRK2 | 0.40728257 |
| 100 | MAPKAPK2 | 0.40552632 |
| 101 | PAK4 | 0.40269862 |
| 102 | ALK | 0.36688336 |
| 103 | ERBB4 | 0.36002430 |
| 104 | MAP3K3 | 0.34773443 |
| 105 | PDPK1 | 0.34620663 |
| 106 | HIPK2 | 0.33215575 |
| 107 | SMG1 | 0.32961666 |
| 108 | MAP3K6 | 0.32571058 |
| 109 | PRKG2 | 0.32130524 |
| 110 | MAP3K8 | 0.29943657 |
| 111 | MAPK4 | 0.29897117 |
| 112 | PKN1 | 0.29446920 |
| 113 | RIPK1 | 0.29429290 |
| 114 | ITK | 0.29292953 |
| 115 | RPS6KA6 | 0.28116198 |
| 116 | CDK6 | 0.27035276 |
| 117 | INSR | 0.26332548 |
| 118 | PLK2 | 0.25880274 |
| 119 | PKN2 | 0.25866110 |
| 120 | PDK1 | 0.25293987 |
| 121 | STK3 | 0.24966861 |
| 122 | TRPM7 | 0.23209211 |
| 123 | SRC | 0.22275815 |
| 124 | PDGFRB | 0.22138020 |
| 125 | TAOK2 | 0.22097482 |
| 126 | IGF1R | 0.20133284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.51612924 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02363518 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.89809558 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.86997848 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.67393989 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.56302916 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.49506009 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.40226131 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.39411156 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.39373697 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.39242065 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.30029924 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.28179738 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.20070280 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 2.12922682 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.07802851 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.02052431 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.98615626 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.97268624 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.92106034 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.87525275 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85378403 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.82167125 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.76701376 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73277991 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.71281290 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69340835 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.61217888 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56205750 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50273746 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43540655 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43500297 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39400962 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37229982 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36483398 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36021770 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.34476491 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.32755915 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27124900 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25063642 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20650474 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12519320 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10724598 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08873228 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.05760659 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.05407780 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01219675 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98191363 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.93758380 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91357344 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88046790 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87964968 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85077245 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83122038 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82801272 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.81529971 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80822216 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72734064 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71363848 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70211511 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.69886533 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68453839 |
| 63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67114445 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67083892 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67028500 |
| 66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65442648 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65276046 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65244895 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65043997 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57630359 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56628502 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55576870 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54071561 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52227328 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51563711 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51402637 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.50062953 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.49838487 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48458706 |
| 80 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39023568 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38105598 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34506531 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34367575 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34009384 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33886980 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.33806465 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33065495 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30859285 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30792399 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30654491 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29709692 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29447809 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.27642573 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26133027 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.25998221 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25919264 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.25795893 |
| 98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23838670 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22155276 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21449631 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20694596 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18386843 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18068839 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17385567 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.17231109 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15893305 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15372141 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15119248 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.13010721 |
| 110 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.11990287 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.08574973 |

